The polo-like kinase 1 (PLK1) inhibits type I interferon induction via interaction with Cardif

被引：0
|
作者：
Vitour, Damien
Dabo, Stephanie
Vidalain, Pierre-Olivier
Vilasco, Myriam
Pour, Malek Ahmadi
Lin, Rongtuan
Hiscott, John
Jacob, Yves
Tangy, Frederic
Meurs, Eliane F.
机构：
[1] Inst Pasteur, Hepacivirus, Paris, France
[2] Inst Pasteur, Viral Genom & Vaccinat, Paris, France
[3] Lady Davis Inst Med Res, Montreal, PQ, Canada
[4] Inst Pasteur, Papilloma Virus & Human Canc, Paris, France
来源：
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2007年 / 27卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [31] Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer
    Lashen, Ayat G.
    Toss, Michael S.
    Wootton, Louisa
    Green, Andrew R. R.
    Mongan, Nigel P.
    Madhusudan, Srinivasan
    Rakha, Emad
    HISTOPATHOLOGY, 2023, 83 (03) : 414 - 425
  • [32] Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes
    Iliaki, Styliani
    Kreike, Marja
    Moreno, Natalia Ferreras
    De Meyer, Femke
    Aidarova, Aigerim
    Braun, Harald
    Libert, Claude
    Afonina, Inna S.
    Beyaert, Rudi
    BIOCHEMICAL PHARMACOLOGY, 2024, 228
  • [33] Polo-like Kinase 1 (PLK1) inhibition synergizes with docetaxel in basal breast cancer cells
    Giordano, A.
    Liu, Y.
    Armeson, K. E.
    Britten, C. D.
    Kappler, C. S.
    Ethier, S. P.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer
    Shao, Chen
    Ahmad, Nihal
    Hodges, Kurt
    Kuang, Shihuan
    Ratliff, Tim
    Liu, Xiaoqi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (04) : 2024 - 2033
  • [35] Overexpression of Polo-like kinase1 (PLK1) in chondrosarcoma and its implications for cancer progression
    Li, Kelu
    Ma, Hongmei
    Zheng, Xiuyan
    Hu, Yali
    Wang, Yue
    Zhang, Kunpeng
    Chen, Jiahan
    Qi, Yan
    Jiang, Jinfang
    Pang, Lijuan
    Tao, Lin
    Gu, Wenyi
    Li, Feng
    Zou, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1707 - 1711
  • [36] Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
    Giordano, Antonio
    Liu, Yueying
    Armeson, Kent
    Park, Yeonhee
    Ridinger, Maya
    Erlander, Mark
    Reuben, James
    Britten, Carolyn
    Kappler, Christiana
    Yeh, Elizabeth
    Ethier, Stephen
    PLOS ONE, 2019, 14 (11):
  • [37] Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
    Biswas, Ayan
    Zhou, Dawei
    Fiches, Guillaume N.
    Wu, Zhenyu
    Liu, Xuefeng
    Ma, Qin
    Zhao, Weiqiang
    Zhu, Jian
    Santoso, Netty G.
    PLOS PATHOGENS, 2021, 17 (07)
  • [38] Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma
    Kanaji, Shingo
    Saito, Hiroaki
    Tsujitani, Shunichi
    Matsumoto, Sachiko
    Tatebe, Shigeru
    Kondo, Akira
    Ozaki, Mitsuhiko
    Ito, Hisao
    Ikeguchi, Masahide
    ONCOLOGY, 2006, 70 (02) : 126 - 133
  • [39] Polo-like kinase 1 (PLK1) and protein kinase IKKε, two markers of cancer, down-regulate IFN induction by MAVS
    Vitour, Damien
    Dabo, Stephanie
    Pour, Malek Ahmadi
    Vilasco, Myriam
    Vidalain, Pierre-Olivier
    Jacob, Yves
    Pineau, Pascal
    Tangy, Frederic
    Hiscott, John
    Meurs, Eliane F.
    CYTOKINE, 2008, 43 (03) : 312 - 312
  • [40] From Plk1 to Plk5 Functional evolution of Polo-like kinases
    de Carcer, Guillermo
    Manning, Gerard
    Malumbres, Marcos
    CELL CYCLE, 2011, 10 (14) : 2255 - 2262
12345